Psoriasis is a common disease with the population prevalence ranging from 2% to 3%. Its
prevalence in the population is affected by genetic, environmental, viral, infectious …

Psoriasis is a chronic autoinflammatory skin disease associated with multiple comorbidities,
with a prevalence ranging from 2 to 3% in the general population. Decades of preclinical …

Background. Psoriasis is a chronic inflammatory skin disease characterized by an
accelerated turnover of epidermal cells and an incomplete differentiation in epidermis with …

Background Psoriasis is an inflammatory dermatosis that is characterized with
hyperproliferation of keratinocytes and inflammatory infiltration in the epidermis and dermis …

Aims: In this study, the serum lipid levels of psoriatic patients were investigated to detect any
relation in this respect. Materials and Methods: 60 psoriatic and 120 nonpsoriatic individuals …

Psoriasis (PSO) is a common skin disease that affects about 1%–3% of the general
population. It is a great medical, social and economic burden since PSO is associated with …

Psoriasis is a common chronic and recurrent inflammatory skin disorder that has been
associated with oxidative stress, abnormal plasma lipid metabolism and with high frequency …

Psoriasis is a chronic inflammatory, immune-mediated skin disease, which affects 2%-3% of
the population worldwide. Chronic plaque psoriasis is frequently associated with metabolic …

Psoriasis is a chronic inflammatory and immune‑mediated condition, which is no longer
considered as being limited to the skin, but may affect the entire body. Epidemiological …

BACKGROUND: Psoriasis appears to have increased cardiovascular morbidity. The
underlying pathogenetic mechanisms remain unclear. Multiple factors, including systemic …